Santen Pharmaceutical Co., Ltd. logo

Santen Pharmaceutical Co., Ltd. (SZD)

Market Open
11 Aug, 06:03
XFRA XFRA
10. 40
-0.1
-0.9524%
- Market Cap
19.29 P/E Ratio
68% Div Yield
50 Volume
0.57 Eps
10.5
Previous Close
Add Transaction
Day Range
10.4 10.4
Year Range
8.05 11.9
Want to track SZD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
12 May 2026
16.01
-
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
5 Feb 2026
24.05
-
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
5 Nov 2025
-
-
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
4 Aug 2025
-
-
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
7 May 2025
-
-
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
6 Feb 2025
-
-
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
5 Nov 2024
-
-
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
1 Aug 2024
-
-
Santen Pharmaceutical Co., Ltd. logo
SZD Santen Pharmaceutical Co., Ltd.
9 May 2024
-
-

SZD Earnings Reports FAQ

What is the earnings per share (EPS) for SZD?

The current EPS is 0.57.

What is the company's earnings growth rate?

Santen Pharmaceutical Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Santen Pharmaceutical Co., Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Santen Pharmaceutical Co., Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for SZD at this time, as Santen Pharmaceutical Co., Ltd has no recent EPS data to calculate it.